A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia
BRITISH JOURNAL OF HAEMATOLOGY(2019)
关键词
BI 811283,low-dose cytarabine,acute myeloid leukaemia,Aurora B kinase,phase I
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要